虹膜角膜内皮综合征的治疗新进展  

Treatment progress of iridocorneal endothelial syndrome

作　　者：赵晴[1] 郭俊国[2] 马晓华[1] 

机构地区：[1]山东中医药大学,中国山东省济南市250355 [2]山东中医药大学眼科研究所山东省中西医结合眼病防治重点实验室,中国山东省济南市250002

出　　处：《国际眼科杂志》2016年第2期258-260,共3页International Eye Science

摘　　要：虹膜角膜内皮综合征(iridocorneal endothelial syndrome,ICES)是临床上比较少见的眼部疾病之一,其发病机制尚不明确,症状复杂,有很高的致盲率。患者常因青光眼、视力减退、眼痛和虹膜异常来就诊。ICES至今尚无理想的治疗方法,临床上只能针对其并发症采取相应的药物、手术治疗。本文将对近期有关ICES治疗进展的文献进行综述,同时对极易出现误诊的疾病进行鉴别,以期对ICES的治疗提供帮助。Iridocorneal endothelial syndrome（ICE syndrome） is one of the relatively rare clinical ocular diseases,of which pathogenesis is not clear.The symptoms are complicated,and the risk of blindness is very high.Patients often see a doctor due to glaucoma,visual loss,eye pain and abnormalities of the iris.Until recently there is not any ideal method to treat the syndrome.In clinical practice,doctors only have to treat the complications of this disease,using medicine or surgeries.This article will review the recent literature on the treatment of ICE syndrome,at the same time to identify the disease prone to misdiagnosis,to provide help for the treatment of ICE syndrome.

关 键 词：虹膜角膜内皮综合征 治疗 并发症 青光眼 角膜水肿 

分 类 号：R773.1[医药卫生—眼科]